v3 Template
I

iOnctura

Biopharmaceuticals / Oncology Geneva and Amsterdam ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$85.8M
Funding Rounds
1
Last Funding
2024-06-20

About iOnctura

iOnctura is a biopharmaceutical company focused on developing high-impact, low-disruption therapies to extend healthspan. Their mission involves disrupting the tumor-stroma-immune interface to target neglected and hard-to-treat cancers, offering more effective and less toxic treatments compared to conventional therapies.

Products & Services

Roginolisib (IOA-244):The first allosteric modulator of PI3Kδ, featuring a unique chemical structure and binding mode, targeting dysregulated pathways in cancer to promote tumor growth and survival.
Cambritaxestat (IOA-289):The only autotaxin inhibitor in clinical development for cancer, inhibiting both catalytic and chaperone activities of the enzyme to address proliferation, migration, and survival of cancer cells.
IOA-359:A novel small molecule TGF-β pathway inhibitor aimed at reducing tumor aggressiveness, immune escape, and resistance to therapy.

Specialties

Precision oral small molecules Oncology research Tumor-stroma-immune interface disruption Development of therapies for neglected and hard-to-treat cancers

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 85800000
MR: -
FA: EUR80 million
FAN: 85800000 		D: 2024-06-20
FD: 2024-06-20 		7 investors
Series B Latest
2024-06-20
$85.8M
7 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Catherine Pickering

CEO and Co-Founder

LinkedIn (Pro only)
L

Lars van Der Veen

Co-Founder, CSO

LinkedIn (Pro only)
M

Michael Lahn

CMO

LinkedIn (Pro only)
E

Elizabeth Holt

Chief Business Officer

S

Steven Sciuto

CFO

M

Michelle Tsai

COO

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

iOnctura Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals / Oncology
Company Size
~420 employees (est.)
Locations
Geneva and Amsterdam

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro